Reprint

Genetic and Epigenetic Regulations of Tumor Progression and Metastasis

Edited by
April 2023
208 pages
  • ISBN978-3-0365-7185-0 (Hardback)
  • ISBN978-3-0365-7184-3 (PDF)

This book is a reprint of the Special Issue Genetic and Epigenetic Regulations of Tumor Progression and Metastasis that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Genetic aberrations and epigenetic modifications are critical drivers of cancer progression and metastasis. Although recurrent mutations in primary and metastatic cancers have been shown to be concordant, there are several metastasis-associated mutations responsible for resistance to specific therapies that are frequently located in genes that regulate DNA methylation and chromatin modifications. Recent studies have shown that distinct subgroups of poor-prognosis tumors lack genetic alterations but are epigenetically regulated, pointing to the critical role of epigenetic modifications in cancer progression. This Special Issue provides novel insights into the mechanisms underlying processes associated with cancer cell plasticity and the development of metastatic disease.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
prostate cancer; metastasis; epithelial-to-mesenchymal transition (EMT); partial-EMT (p-EMT); Zeb1; DNA methylation; 5-azacytidine; lung adenocarcinoma; brain metastasis; omics data analysis; CDKN2A; p16; invasive ductal breast cancer; CDH1 gene; EMT genes; miRNA and mRNA expression; E-cadherin; HTR2B; STAT proteins; uveal melanoma; promoter; gene transcription; PDAC; inflammation; hypoxia; epithelial-to-mesenchymal transition; DNA methylation; cancer proliferation; hepatocellular carcinoma; metastasis; engineered exosomes; diagnostic biomarker; cancer therapy; angiogenesis; pericytes; adipose tissue; cell adhesion; endothelial cells; breast cancer; metastatic cascade; intra-tumor heterogeneity; mutational profile; adaptive responses; autophagy; tumor mutational burden; tumor microenvironment; waterpipe smoke; lung cancer; n/a; CYSLTR1; CYSLTR2; methylation; prognosis; metastasis; colorectal cancer; EMT